Syringes Market

Global Syringes Market Size

The global syringes market size was estimated at USD 15.27 billion in 2024 and is estimated to be USD 31.55 billion by 2033 and USD 16.55 billion in 2025, growing at a CAGR of 8.40% during the forecast period.

Syringes consist of a tube and a plunger attached to a needle. The Syringe is a piece of medical equipment used to emit fluids into a body and can be used to extract fluids like blood from the body. The fluids, like blood, etc., will enter a tube through a needle when a plunger handle is pulled, and the liquid will go out through the needle when the plunger is pushed down. The World Health Organization (WHO) has urged all to use disposable syringes for safe injection practices. According to WHO, more than 16 billion injections are being used worldwide.

MARKET DRIVERS

YOY Rise in the Prevalence of Chronic Diseases

Syringes play an essential role in the treatment procedure of any disease. Furthermore, these syringes inject drugs or vaccines into the body. Therefore, the global syringes market will witness healthy growth during the forecast period. In addition, the increase in the use of prefilled syringes and an increase in the adoption of injectable drugs fuel the market. Moreover, the rise in the demand for Botox for therapeutic applications is boosting the market. Furthermore, the growing adoption of technological advancements and the launch of various devices favoring end-users is favoring the market’s growth rate. In addition, an increase in surgical procedures is boosting the market. Due to the increasing many health problems for the injection drug providers to patients for some diseases such as human immunodeficiency virus (HIV) and hepatitis B and C., These risks can be reduced by using the proper syringes, which developed the market growth.

In addition, the growing usage of biologics in the treatment procedures of various diseases propels the syringes market growth. In addition, increasing clinical success, demand for home healthcare, and cases of different diseases are the factors of demand for self-injection devices that help the market grow. Furthermore, the growing R&D activities around syringes to reduce needle stick injuries and increasing investment in the production of syringes by many vital players also promote the growth rate of the syringes market. As a result, manufacturers are focusing on developing different types of syringes based on the type of diseases and the vaccine they inject.

Furthermore, the vaccination and immunization drive for viruses such as COVID-19, typhoid, and others is expected to be a significant growth opportunity for the syringes market. In addition, government investments in hospitals will help the market in the coming years. With the increasing government's strict rules for vaccination by all the people in the world, the production of syringes has increased to meet the supply and demand in the world. Furthermore, the growing awareness regarding vaccination and the increasing number of vaccination programs worldwide is further resulting in the growing usage of syringes, which is also expected to boost the market growth.

MARKET RESTRAINTS

High costs associated with safety syringes are a major factor hampering the market growth. Moreover, the availability of alternative drug delivery methods is hindering the market. In addition, the risk of infection and the use of contaminated syringes by reusable syringes are stopping the market growth. Using glass syringes may also break, which leads to the spread of the fluid with glass material, harms the patients and healthcare provider bodies, and impedes market growth. Furthermore, day by day, needle stick injuries are increasing, which limits the market growth. Due to a lack of awareness of healthcare and safety issues, emerging countries need to pay more attention to safe syringes, which will be a significant challenge for market growth. Furthermore, after the completion of the COVID-19 vaccination period, the production of syringes has decreased due to less adoption of the Syringe by hospitals and clinics, which also slowed down the market growth.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Usability Insights

Based on usability, the disposable syringes segment is expected to command a larger share of the global syringes market due to the increasing use of injectable drug delivery, the rising geriatric population, and the increased risk of infection with reusable syringes. Disposable syringes are environmentally friendly, and the production of disposable syringes is easy to compare to the others. Furthermore, due to increasing health conciseness among people, they prefer to have vaccines through a disposable syringe, reducing the spread of any virus. These are most helpful in reducing the risk of infections and harmful diseases. In addition, an increase in the use of injectable drug delivery helped the market grow. Moreover, the rising geriatric population led the market leader in the forecast period.

The prefilled syringes segment will witness the fastest growth in the forecast period due to the growing incidence of chronic diseases such as cancer, cardiovascular diseases, and diabetes, fueling the segment's growth. For instance, most diabetic people use prefilled syringes to avoid errors in taking the drug dosage. Even high and low insulin content taken into the body may result in severe consequences, which may lead to death also. In addition, the people who stay away from the town and the disabled people prefer to use a prefilled syringe to reduce the travel risk in critical situations.

By Material Insights

Based on material, the glass syringes segment accounted for the largest share of the global syringes market in 2024, and the domination of the segment is expected to continue during the forecast period. This is because glass syringes are more effective and decrease the chances of syringe material reacting with fluid and can be reused. In addition, manufacturing glass-type syringes with unbreakable features also demands the segment's growth.

The plastic syringe market is growing consistently and is predicted to showcase a CAGR of 8.84% during the forecast period owing to the rising awareness regarding blood-borne infections. In addition, the easy disposal of plastic-related syringes and the easy process of manufacturing these syringes are propelling segmental growth.

By Type Insights

The specialized syringes segment is estimated to grow significantly during the forecast period based on the type. The specialized syringes market is the largest revenue grantor. The increasing demand for injectable drugs has fueled the market. The insulin segment has the highest market share. Due to the increasing insulin intake by a large volume of people due to the increase in glucose levels, demand for the manufacturing of different types of syringes is promoting segmental expansion. On the other hand, the available syringes market is growing its share daily during the forecast period.

Due to changing lifestyle habits, environmental pollution results in increasing allergy-related diseases, which demand the growth of syringes which does not contaminate or spread to the other person while injecting the patient.

REGIONAL ANALYSIS

Geographically, the syringes market in North America is predicted to dominate the global syringes market with the highest share, followed by Europe. The growing number of patients suffering from chronic diseases and infectious diseases across the North American region has resulted in the growing usage of syringes and the promotion of the growth of the regional market. Furthermore, advanced drug delivery technology, specialized syringes, and higher spending limits are the main reasons for market growth. In North America, the United States contributes a significant market share. According to CDC reports, one hundred million people in the United States live with diabetes and pre-diabetes. So, insulin syringes are primarily used in the treatment of diabetes. In addition, the spread rate of infection and prevalence of diseases is high because of the US's high population. These are the significant factors that have led to North America's dominance in the global syringes market.

However, the Asia-Pacific syringes market is expected to increase at the highest CAGR owing to growing technological advancements, healthcare facilities, and the aging population. As a result, the Asia-Pacific is the fastest-growing region in the Global Syringes Market. Government support through funding is the main reason for market growth in Asia-Pacific. The major contributors to the market are India and China. In addition, the growing healthcare facilities are a significant factor.

Furthermore, technological advancements in developing countries have boosted the market. Currently, the production of the syringe market is in high demand in China due to the increasing number of new variants and the restart of booster doses in China and other countries. In addition, the increase in awareness of the advantages of prefilled syringes and the aging population in countries like Japan and China fuel the market.

The European syringes market is expected to grow at a prominent CAGR during the forecast period. The government initiative support through funding is dominating the market. The United Kingdom's syringes market is the largest in Europe and is estimated to continue throughout the forecast period. Germany is known for the development and industrialization of new syringes. Because of its healthcare infrastructure and the pharmaceutical industry, Russia is the fastest-growing country in Europe.

The Latin American Syringes Market is predicted to grow steadily during the forecast period.

Simultaneously, the MEA Syringes Market is forecasted to gain momentum in a couple of years and register stable market growth by the end of the forecast period.

KEY MARKET PLAYERS

Companies leading the global syringes market profiled in the report are Terumo Corporation, 8. Braun Medical Inc., Medtronic plc, Becton Dickinson and Company, Smiths Medical, Hindustan Syringes & Medical Devices Limited, NIPRO Corporation, Gerresheimer AG, SCHOTT AG, and CODAN Medizinische Generate GmbH & Co KG.

New Product Launches and Collaborations are some notable strategies adopted by the companies operating in this market to maintain and maximize their market share. In addition, the recent COVID-19 pandemic has fuelled the sales of syringes across the globe, and market participants have taken new initiatives to manage the increased demand.

RECENT HAPPENINGS IN THE MARKET

• In 2022, Nephron Pharmaceuticals Corporation launched a brand-new syringe suitable for different medications, including highly viscous drugs.
• In 2022, Owen Mumford Ltd. announced that the UniSafe 1mL safety device for prefilled syringes has been approved in Asia and is used to treat rheumatoid arthritis.
• In 2021, the Serum Institute of India partnered to provide cartridges and syringes in bulk and nested solutions.
• In 2020, Hindustan Syringes shipped the last consignment of 140 mn AD syringes for the COVAX, and Hindustan Syringes had increased the production to 1 billion for the demand of the COVID-19 vaccine.

MARKET SEGMENTATION

This research report on the global syringes market has been segmented and sub-segmented based on usability, material, type, specialized syringes, and region.

By Usability

• Sterilizable/Reusable Syringes
  • Hypodermic Syringes
  • Oral Syringes
• Disposable Syringes
  • Conventional Syringes
  • Safety Syringes
• Prefilled Syringes
  • Safety Syringes
  • Retractable Syringes
  • Non-Retractable Syringes

By Material

• Glass

• Plastic

By Type

• General
• Specialized Syringes
  • Insulin
  • Tuberculin
  • allergy

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa